(NASDAQ: QNTM) Quantum Biopharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 0.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 53.77%.
Quantum Biopharma's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast QNTM's revenue for 2025 to be $23,532,218, with the lowest QNTM revenue forecast at $23,532,218, and the highest QNTM revenue forecast at $23,532,218.
In 2026, QNTM is forecast to generate $40,530,721 in revenue, with the lowest revenue forecast at $40,530,721 and the highest revenue forecast at $40,530,721.